CD8 Epitope Escape and Reversion in Acute HCV Infection

In the setting of acute hepatitis C virus (HCV) infection, robust HCV-specific CD8+ cytotoxic T lymphocyte (CTL) responses are associated with initial control of viremia. Despite these responses, 70–80% of individuals develop persistent infection. Although viral escape from CD8 responses has been illustrated in the chimpanzee model of HCV infection, the effect of CD8 selection pressure on viral evolution and containment in acute HCV infection in humans remains unclear. Here, we examined viral evolution in an immunodominant human histocompatibility leukocyte antigen (HLA)-B8–restricted NS3 epitope in subjects with acute HCV infection. Development of mutations within the epitope coincided with loss of strong ex vivo tetramer and interferon γ enzyme-linked immunospot responses, and endogenous expression of variant NS3 sequences suggested that the selected mutations altered processing and presentation of the variant epitope. Analysis of NS3 sequences from 30 additional chronic HCV-infected subjects revealed a strong association between sequence variation within this region and expression of HLA-B8, supporting reproducible allele-specific selection pressures at the population level. Interestingly, transmission of an HLA-B8–associated escape mutation to an HLA-B8 negative subject resulted in rapid reversion of the mutation. Together, these data indicate that viral escape from CD8+ T cell responses occurs during human HCV infection and that acute immune selection pressure is of sufficient magnitude to influence HCV evolution.

[1]  Michael P. Cummings,et al.  PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .

[2]  J. Rakela,et al.  Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. , 2004, Gastroenterology.

[3]  P. Kloetzel,et al.  Hepatitis C virus mutation affects proteasomal epitope processing. , 2004, The Journal of clinical investigation.

[4]  Alessandro Sette,et al.  Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[5]  M. Altfeld,et al.  Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection , 2004, The Journal of experimental medicine.

[6]  Edward C. Holmes,et al.  High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression , 2004, Journal of Virology.

[7]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[8]  John Sidney,et al.  Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.

[9]  P. Narciso,et al.  Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Yoshiyuki Nagai,et al.  Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[11]  Todd M. Allen,et al.  Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[12]  B. Walker,et al.  Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection , 2004, Springer Seminars in Immunopathology.

[13]  Charles M. Rice,et al.  HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help , 2003, Science.

[14]  B. Walker,et al.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. , 2003, The Journal of clinical investigation.

[15]  B. Rehermann,et al.  Hepatitis C virus infection: when silence is deception. , 2003, Trends in immunology.

[16]  J. Ghrayeb,et al.  Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.

[17]  P. Klenerman,et al.  Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers. , 2003, Immunology letters.

[18]  M. Massari,et al.  Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C , 2002, Journal of Virology.

[19]  J. Hoofnagle,et al.  Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.

[20]  P. Klenerman,et al.  The dynamics of T‐lymphocyte responses during combination therapy for chronic hepatitis C virus infection , 2002, Hepatology.

[21]  B. Walker,et al.  Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.

[22]  B. Walker,et al.  Cellular immune responses against hepatitis C virus: the evidence base 2002 , 2002, Clinical and experimental immunology.

[23]  E. Rosenberg,et al.  Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses , 2002, Journal of Virology.

[24]  A. Hughes,et al.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.

[25]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[26]  K. Cao,et al.  Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. , 2001, Human immunology.

[27]  P. Klenerman,et al.  Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection , 2001, European journal of immunology.

[28]  B. Walker,et al.  Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus , 2001, Journal of Virology.

[29]  F. Zoulim,et al.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. , 2001, Gastroenterology.

[30]  H. Ljunggren,et al.  Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance , 2000, Nature Medicine.

[31]  Alessandro Sette,et al.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.

[32]  D. Moskophidis,et al.  Viral Escape by Selection of Cytotoxic T Cell–Resistant Variants in Influenza a Virus Pneumonia , 2000, The Journal of experimental medicine.

[33]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[34]  N. Goldman,et al.  Codon-substitution models for heterogeneous selection pressure at amino acid sites. , 2000, Genetics.

[35]  H J Alter,et al.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.

[36]  R. Chapman,et al.  Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus , 1999, Hepatology.

[37]  T. Santantonio,et al.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.

[38]  M. Davis,et al.  Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[40]  E. Gilboa,et al.  Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA , 1998, Nature Biotechnology.

[41]  M. Houghton,et al.  Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C , 1998 .

[42]  A. Sette,et al.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.

[43]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[44]  D. Lamarre,et al.  Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors , 1997, Journal of virology.

[45]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[46]  F. Chisari,et al.  Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. , 1996, The Journal of clinical investigation.

[47]  B. Walker,et al.  HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. , 1995, The Journal of clinical investigation.

[48]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[49]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[50]  K. Ching,et al.  A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants , 1993, Journal of virology.

[51]  R. Zinkernagel,et al.  In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.